Literature DB >> 25547404

Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size.

Andreas Mangold1, Sherin Alias1, Thomas Scherz1, Thomas Hofbauer1, Johannes Jakowitsch1, Adelheid Panzenböck1, Daniel Simon1, Daniela Laimer1, Christine Bangert1, Andreas Kammerlander1, Julia Mascherbauer1, Max-Paul Winter1, Klaus Distelmaier1, Christopher Adlbrecht1, Klaus T Preissner1, Irene M Lang2.   

Abstract

RATIONALE: Mechanisms of coronary occlusion in ST-elevation acute coronary syndrome are poorly understood. We have previously reported that neutrophil (polymorphonuclear cells [PMNs]) accumulation in culprit lesion site (CLS) thrombus is a predictor of cardiovascular outcomes.
OBJECTIVE: The goal of this study was to characterize PMN activation at the CLS. We examined the relationships between CLS neutrophil extracellular traps (NETs), bacterial components as triggers of NETosis, activity of endogenous deoxyribonuclease, ST-segment resolution, and infarct size. METHODS AND
RESULTS: We analyzed coronary thrombectomies from 111 patients with ST-elevation acute coronary syndrome undergoing primary percutaneous coronary intervention. Thrombi were characterized by immunostaining, flow cytometry, bacterial profiling, and immunometric and enzymatic assays. Compared with femoral PMNs, CLS PMNs were highly activated and formed aggregates with platelets. Nucleosomes, double-stranded DNA, neutrophil elastase, myeloperoxidase, and myeloid-related protein 8/14 were increased in CLS plasma, and NETs contributed to the scaffolds of particulate coronary thrombi. Copy numbers of Streptococcus species correlated positively with dsDNA. Thrombus NET burden correlated positively with infarct size and negatively with ST-segment resolution, whereas CLS deoxyribonuclease activity correlated negatively with infarct size and positively with ST-segment resolution. Recombinant deoxyribonuclease accelerated the lysis of coronary thrombi ex vivo.
CONCLUSIONS: PMNs are highly activated in ST-elevation acute coronary syndrome and undergo NETosis at the CLS. Coronary NET burden and deoxyribonuclease activity are predictors of ST-segment resolution and myocardial infarct size.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  atherosclerosis; coronary occlusion; coronary thrombosis; deoxyribonucleases; extracellular traps; myocardial infarction; neutrophils

Mesh:

Substances:

Year:  2014        PMID: 25547404     DOI: 10.1161/CIRCRESAHA.116.304944

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  137 in total

1.  Von Willebrand factor is reversibly decreased during torpor in 13-lined ground squirrels.

Authors:  Scott Cooper; Shawn Sell; Luke Nelson; Jennifer Hawes; Jacob A Benrud; Bridget M Kohlnhofer; Bradley R Burmeister; Veronica H Flood
Journal:  J Comp Physiol B       Date:  2016-01       Impact factor: 2.200

Review 2.  Neutrophil Extracellular Traps Participate in Cardiovascular Diseases: Recent Experimental and Clinical Insights.

Authors:  Yvonne Döring; Peter Libby; Oliver Soehnlein
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

3.  Nuclear factor kappa B in patients with a history of unstable angina: case re-opened.

Authors:  Chiara Mozzini; Ulisse Garbin; Chiara Stranieri; Giulia Salandini; Giancarlo Pesce; Anna Maria Fratta Pasini; Luciano Cominacini
Journal:  Intern Emerg Med       Date:  2018-06-01       Impact factor: 3.397

4.  NETosis promotes cancer-associated arterial microthrombosis presenting as ischemic stroke with troponin elevation.

Authors:  Charlotte Thålin; Melanie Demers; Bo Blomgren; Siu Ling Wong; Magnus von Arbin; Anders von Heijne; Ann Charlotte Laska; Håkan Wallén; Denisa D Wagner; Sara Aspberg
Journal:  Thromb Res       Date:  2016-01-12       Impact factor: 3.944

Review 5.  Mouse models of cancer-associated thrombosis.

Authors:  Yohei Hisada; Nigel Mackman
Journal:  Thromb Res       Date:  2017-12-29       Impact factor: 3.944

Review 6.  Neutrophils: back in the thrombosis spotlight.

Authors:  Denis F Noubouossie; Brandi N Reeves; Brian D Strahl; Nigel S Key
Journal:  Blood       Date:  2019-03-21       Impact factor: 22.113

Review 7.  Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil-platelet interactions.

Authors:  Alicia García-Culebras; Violeta Durán-Laforet; Carolina Peña-Martínez; Iván Ballesteros; Jesús M Pradillo; Jaime Díaz-Guzmán; Ignacio Lizasoain; María A Moro
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-21       Impact factor: 6.200

Review 8.  Innate immunity as a target for acute cardioprotection.

Authors:  Coert J Zuurbier; Antonio Abbate; Hector A Cabrera-Fuentes; Michael V Cohen; Massimo Collino; Dominique P V De Kleijn; James M Downey; Pasquale Pagliaro; Klaus T Preissner; Masafumi Takahashi; Sean M Davidson
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

9.  Flow Perturbation Mediates Neutrophil Recruitment and Potentiates Endothelial Injury via TLR2 in Mice: Implications for Superficial Erosion.

Authors:  Grégory Franck; Thomas Mawson; Grasiele Sausen; Manuel Salinas; Gustavo Santos Masson; Andrew Cole; Marina Beltrami-Moreira; Yiannis Chatzizisis; Thibault Quillard; Yevgenia Tesmenitsky; Eugenia Shvartz; Galina K Sukhova; Filip K Swirski; Matthias Nahrendorf; Elena Aikawa; Kevin J Croce; Peter Libby
Journal:  Circ Res       Date:  2017-04-20       Impact factor: 17.367

10.  Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice.

Authors:  Konstantin Stark; Vanessa Philippi; Sven Stockhausen; Johanna Busse; Antonella Antonelli; Meike Miller; Irene Schubert; Parandis Hoseinpour; Sue Chandraratne; Marie-Luise von Brühl; Florian Gaertner; Michael Lorenz; Alessandra Agresti; Raffaele Coletti; Daniel J Antoine; Ralf Heermann; Kirsten Jung; Sven Reese; Iina Laitinen; Markus Schwaiger; Axel Walch; Markus Sperandio; Peter P Nawroth; Christoph Reinhardt; Sven Jäckel; Marco E Bianchi; Steffen Massberg
Journal:  Blood       Date:  2016-08-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.